Trabedersen

OT-101

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trabedersen, covering 2025-07-24 to 2025-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1 [Phase 1, Phase 2]